Talbot, Susan M <br/><br/>
High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.  [electronic resource] 

 -  Cancer  Jul 2003 
 - 331-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.11512  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Disease-Free Survival<br/>Drug Therapy, Combination<br/>Female<br/>Granulocyte Colony-Stimulating Factor--adverse effects<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Male<br/>Mesna--administration & dosage<br/>Mesothelioma--drug therapy<br/>Middle Aged<br/>Pleural Neoplasms--drug therapy<br/>Protective Agents--administration & dosage<br/>Recombinant Proteins<br/>Treatment Outcome